More than a decade after the sizzle of genomics investments has faded, Amgen, an American biotechnology giant, is buying out one of the field’s most important firms, deCODE Genetics.
Read more @ SciTechDaily
More than a decade after the sizzle of genomics investments has faded, Amgen, an American biotechnology giant, is buying out one of the field’s most important firms, deCODE Genetics.
Read more @ SciTechDaily